http://goldbamboo.com/ ACE News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved http://goldbamboo.com/news-a216881.html Angiotensin-receptor blockers (ARBs) and angiotensin-converting-enzyme inhibitors (ACE) are the antihypertensive agents least associated with incident diabetes according to an Article in the Lancet.The propensity for some blood pressure-lowering drugs to reduce glucose tolerance and precipitate diabetes is well known. [click link for full article] Tue, 23 Jan 2007 12:00 EST http://goldbamboo.com/news-a216705.html Researchers at Rush University Medical Center analyzed the data from 22 randomized clinical trials, and have found significant differences between antihypertensive drugs. ACE-inhibitors and the newer angiotensin receptor blockers, or ARBs prevent people from getting diabetes, and the older diuretics or beta-blockers, increase the chance that a person becomes diabetic, compared to either placebo (inactive sugar-pills) or calcium channel blockers according to a study published in the January 20, 2007 issue of the Lancet. Mon, 22 Jan 2007 04:00 EST http://goldbamboo.com/news-a211054.html Common blood pressure medications might help block the spread of pancreatic cancer, researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found. The scientists showed in laboratory studies that two types of pressure-lowering drugs - ACE inhibitors and AT1R blockers - may help reduce the development of tumor-feeding blood vessels, a process called angiogenesis. [click link for full article] Tue, 12 Dec 2006 06:00 EST http://goldbamboo.com/news-a210743.html Common blood pressure medications might help block the spread of pancreatic cancer, researchers have found. The scientists showed in laboratory studies that two types of pressure-lowering drugs -- ACE inhibitors and AT1R blockers -- may help reduce the development of tumor-feeding blood vessels, a process called angiogenesis. Such drugs, they say, may become part of a novel strategy to control the growth and spread of cancer. Fri, 08 Dec 2006 04:00 EST http://goldbamboo.com/news-a204874.html NEW YORK (Reuters Health) - Results of a study indicate that patients with high blood pressure and type 2 diabetes benefit from taking an angiotensin-converting-enzyme (ACE) inhibitor to lower blood pressure, even if they have no evidence of kidney or heart disease. Thu, 02 Nov 2006 05:06 EST